MAT's Clinic
Telehealth Protocol Card
Evidence-based treatment protocols used by our board-certified providers. For licensed clinician reference.
OUD Protocol
Opioid Use Disorder → Suboxone (Buprenorphine/Naloxone)
Confirm Withdrawal Readiness
≥ 12 hours since last opioid use + withdrawal present (≥ 3 symptoms: sweating, yawning, restlessness, GI distress, anxiety, piloerection, mydriasis)
Initial Dose
4 mg SL → observe 45–60 min for precipitated withdrawal
Repeat PRN
Repeat 4 mg as needed — Maximum Day 1 dose: 8–12 mg
Day 2 Dosing
Total Day 1 dose (12–16 mg typical)
Maintenance Target
Comfort Medications
AUD Protocol
Alcohol Use Disorder → Naltrexone
Eligibility Criteria
Seizure history
None
Liver disease
None
Opioid-free
7–10 days
Oral Dosing
Injectable Alternative
Clinical Effect
Comfort Medications
Adjunct Protocol
GLP-1 Agonist Adjunct Therapy
Indication
Persistent cravings ± comorbid obesity. Emerging evidence supports GLP-1 agonists as adjuncts in addiction treatment by modulating dopamine reward pathways.
Semaglutide
Weekly subcutaneous injection
Tirzepatide
Weekly subcutaneous injection
Clinical Effect
Clinical Reference Only. These protocols are intended for use by licensed healthcare providers at MAT's Clinic. They do not constitute medical advice for patients. All treatment decisions must be made by a qualified clinician based on individual patient assessment. For patient inquiries, please visit our addiction treatment page.
Ready to start treatment?
Our board-certified addictionologist is accepting new patients. Same-day appointments available.